Early operable breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11864-000-0032-y.pdf
Reference69 articles.
1. Greenlee RT, Murray T, Bolden S, et al.: Cancer statistics, 2000. CA Cancer J Clin 2000, 50:7–33.
2. Dignam JJ: Differences in breast cancer prognosis among African-American and Caucasian women. CA Cancer J Clin 2000, 50:50–64.
3. Fremgen AM, Bland KI, McGinnis LS, et al.: Clinical highlights from the National Cancer Data Base, 1999. CA Cancer J Clin 1999, 49:145–158.
4. Anonymous: Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative Group. Lancet 1998, 352:930–942. The Oxford Overview provides important data on the benefits of polychemotherapy in the adjuvant setting.
5. Anonymous: Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative Group [see comments]. Lancet 1998, 351:1451–1467. The Oxford Overview updates information on the benefits of adjuvant hormonal therapy in both postmenopausal and premenopausal women, and indicates an apparent lack of benefit in ER-negative tumors.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tualang honey adjunct with anastrozole improve parenchyma enhancement of breast tissue in breast cancer patients: A randomized controlled trial;Integrative Medicine Research;2018-12
2. FDG-PET Dynamic Contrast-Enhanced CT in the Management of Breast Cancer;PET Clinics;2009-07
3. Recent advances in endocrine therapy for postmenopausal women with early breast cancer: implications for treatment and prevention;Annals of Oncology;2004-12
4. Immediate Gene Expression Changes After the First Course of Neoadjuvant Chemotherapy in Patients with Primary Breast Cancer Disease;Clinical Cancer Research;2004-10-01
5. Measurement of Volumetric and Vascular Changes with Dynamic Contrast Enhanced MRI for Cancer Therapy Monitoring;Technology in Cancer Research & Treatment;2002-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3